Full metadata record
|dc.description.abstract||Objectives: Structured treatment programs have been recommended for management of patients with chronic conditions to overcome ill-coordinated care. We aimed to evaluate a disease management program (DMP) for diabetes mellitus patients in Switzerland. Methods: We performed a prospective observational study with a propensity score-matched usual care control group from a claims database. We included type-1 and type-2 diabetes patients from a primary care setting. The DMP (intervention) comprised a structured treatment approach with an individual treatment plan, treatment goals and an interprofessional team approach. Our comprehensive outcome measures included quality of life (QOL: EQ-5D-5L), pre-defined indicators for diabetes guideline adherence, number of used services and direct medical costs. We applied a difference-in-difference (DID) approach to compare DMP with usual care (follow-up 1 year). Costs were calculated with non parametric bootstrapping (2017 Swiss Francs, CHF; conversion rate to Euros: 0.85) from a third-party payer perspective (Swiss health care insurance). Results: QOL in a sub-sample of 80 patients did not change during follow-up (mean utility 0.89 at baseline and follow-up; p=0.94). Guideline adherence showed slight improvements for DMP. For example, “non-adherence” (baseline DMP: 19%) decreased in the DMP group by -3 %-points (DID; 95%-CI: -0.07 to 0.01) but not in the control group. A general trend emerged, though mostly not statistically significant, with less used services in the DMP group compared to the control group. Costs increased in both groups during follow-up, but the increase was higher in the control group (DID, mean total costs per patient per year: CHF -950.00 [95%-CI: -1959.53 to 59.56]). Such a negative difference-in-difference estimate in favor of DMP also emerged for cost sub-categories (e.g. costs for inpatient and outpatient care). Conclusions: The structured treatment program under evaluation is a promising approach to improve diabetes care in a Swiss primary care setting but more follow-up data are needed.||de_CH|
|dc.relation.ispartof||Value in Health||de_CH|
|dc.rights||Licence according to publishing contract||de_CH|
|dc.subject.ddc||362: Gesundheits- und Sozialdienste||de_CH|
|dc.subject.ddc||616: Innere Medizin und Krankheiten||de_CH|
|dc.title||Impact of a diabetes disease management program on quality of care and costs : propensity score-matched real-world data from Switzerland||de_CH|
|zhaw.departement||School of Management and Law||de_CH|
|zhaw.organisationalunit||Winterthurer Institut für Gesundheitsökonomie (WIG)||de_CH|
|zhaw.conference.details||Virtual ISPOR Europe 2020, Online, 16-19 November 2020||de_CH|
|zhaw.publication.review||Peer review (Abstract)||de_CH|
|zhaw.funding.zhaw||Wissenschaftliche Begleitevaluation Disease-Management-Programm Diabetes Mellitus||de_CH|
|Appears in collections:||Publikationen School of Management and Law|
Files in This Item:
There are no files associated with this item.
Show simple item record
Carlander, M., Höglinger, M., Trottmann, M., Rhomberg, B., Caviglia, C., Rohrbasser, A., Frei, C., & Eichler, K. (2020). Impact of a diabetes disease management program on quality of care and costs : propensity score-matched real-world data from Switzerland [Conference presentation]. Value in Health, 23(Supplement 2), S516. https://doi.org/10.1016/j.jval.2020.08.658
Carlander, M. et al. (2020) ‘Impact of a diabetes disease management program on quality of care and costs : propensity score-matched real-world data from Switzerland’, in Value in Health. Elsevier, p. S516. Available at: https://doi.org/10.1016/j.jval.2020.08.658.
M. Carlander et al., “Impact of a diabetes disease management program on quality of care and costs : propensity score-matched real-world data from Switzerland,” in Value in Health, 2020, vol. 23, no. Supplement 2, p. S516. doi: 10.1016/j.jval.2020.08.658.
Carlander, Maria, et al. “Impact of a Diabetes Disease Management Program on Quality of Care and Costs : Propensity Score-Matched Real-World Data from Switzerland.” Value in Health, vol. 23, no. Supplement 2, Elsevier, 2020, p. S516, https://doi.org/10.1016/j.jval.2020.08.658.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.